in

AstraZeneca bolsters Covid-19 vaccine supply with new deal

AstraZeneca has expanded its agreement with cell therapy firm Oxford Biomedica to mass-produce its COVID-19 potential vaccine, as it looks to scale-up supply ahead of a possible U.S. fast-track approval.

Source: Business - cnbc.com

Eurozone slides into deflation for the first time in four years

Ford plans to cut 1,000 salaried jobs in North America